Biotech Square (@BiotechSquare) profile picture

We're building AI-powered technology to address the high risk of delay and failure in the development of innovative medical products.

Toronto, Ontario
Joined April 2018
Photo by Biotech Square (@BiotechSquare)Photo by Biotech Square (@BiotechSquare)
Hey #FDATwitter, #MedTwitter, What questions would you ask #FDA on your drug development programs? We're working on an #AI technology to deliver instant evidence-backed answers. What questions would you ask? #RegAffairs #FDASubmissions #ClinDev youtu.be/817Ja5FklEg
3
3
What is a #FileOverProtest? When a company requests to file their application even though a refuse to file action has been taken by #FDA. #RegulatoryForesight found 135 FDA-approved products associated with a "File Over Protest" request. bit.ly/2ZZSafp
2
3
The results are in: congratulations to our 26 McGill Dobson Cup powered by National Bank 2021 finalists! Read more about their startups: mcgill.ca/x/oTX The finals will take place on March 29-30, stay tuned for the official announcement.
3
2
10
Why do we still fail to represent our socio-demographic differences in #clinicaltrials? Our #AI powered tech picks up on this issue in #FDA reviewer comments: “The majority of patients were male, White, and treated in the US” bit.ly/37M3BKY #Diversity #MedicalResearch
2
1
There are over 3,000 registered #COVID19 studies with half of them in active recruitment. Historical trends in #InfectiousDiseases clinical trials can help de-risk these studies and avoid delays. #BiotechSquare #Vaccines #ClinicalResearch link.medium.com/o2o3Q923i9
We're using #ArtificialIntelligence to transform #clinicaltrial failures into lessons. Our team has been hard at work getting ready for the launch. Schedule a time with us to get a sneak peek. link.medium.com/nhk7JKUHn7
1
1
Biotech Square retweeted
Scientists have discovered an elusive 'tangled knot' of #DNA #Science sciencedaily.com/releases/20… … via @ScienceDaily
2
2
Why The Future Of Precision Medicine Runs Through The IVF Lab via @forbes forbes.com/sites/davidsable/…